The Road Ahead for the Acute Bacterial Skin And Skin Structure Infections Market: Key Growth Trends and Opportunities to Watch
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What CAGR is Anticipated for the Acute Bacterial Skin And Skin Structure Infections Market During the Forecast Period, and Why?
In recent times, the market size for acute bacterial skin and skin structure infections has seen rapid expansion. The market is projected to increase from $11.75 billion in 2024 to $13.03 billion in 2025, signaling a compound annual growth rate (CAGR) of 10.9%. The historic growth is driven by factors like innovation in healthcare industry, economic variables, patient population dynamics, progress in diagnostic techniques, and novel approaches to clinical trials.
In the coming years, the market for acute bacterial skin and skin structure infections is anticipated to witness substantial growth. Its value is projected to rise to $18.99 billion by 2029, with a compound annual growth rate (CAGR) of 9.9%. Factors such as global epidemiological conditions, introduction of new therapies, swift diagnostic instruments, a patient-centered approach, and changing treatment protocols contribute to this projected growth during the forecast period. The forecast period is also expected to be impacted by trends including demographic shifts in patient population, anxiety about antibiotic resistance, progress in treatment plans, an increased prevalence of methicillin-resistant staphylococcus aureus (mrsa), and a heightened emphasis on outpatient care.
What Strategic Factors Are Influencing the Accelerated Growth of the acute bacterial skin and skin structure infections Market?
The escalating incidence of skin infections is anticipated to fuel the expansion of the acute bacterial skin and skin structure infections market in the future. These infections occur when various microorganisms, including bacteria, fungi, or viruses, proliferate within the skin, resulting in an array of symptoms and discomfort. As skin infections increase, this elevates demand for therapeutic solutions, antibiotics, and novel treatments to tackle acute bacterial and skin structure infections. This ensures that patients have access to high-quality care and outcomes. For example, as reported by the World Health Organization in March 2023, nearly 1.8 billion individuals worldwide are affected by skin conditions at any given time. Of these, neglected tropical diseases constitute about 10%, with 34% accounted for by fungal and 23% by bacterial infections, frequently leading to high fatality rates. Therefore, the increasing incidence of skin infections is expected to stimulate the expansion of the acute bacterial skin and skin structure infections market.
Acute Bacterial Skin And Skin Structure Infections Market Driver: Increasing Prevalence Of Chronic Diseases To Drive The Growth Of Acute Bacterial Skin And Skin Structure Infections Market
Request Your Free Acute Bacterial Skin And Skin Structure Infections Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13282&type=smp
Which Companies Are Poised to Shape the Future of the Acute Bacterial Skin And Skin Structure Infections Market?
Major companies operating in the acute bacterial skin and skin structure infections market report are:
• Pfizer Inc._x000D_
• AbbVie Inc._x000D_
• Novartis AG_x000D_
• Abbott Laboratories_x000D_
• Fresenius SE & Co. KGaA_x000D_
What Are the Latest Innovations and Trends Influencing the Acute Bacterial Skin And Skin Structure Infections Market?
Major players in the acute bacterial skin and skin structure infections market are concentrating on the development of innovative single-dose treatments like Dalbonova, to maintain their competitiveness. This single-dose therapy, Dalbonova, allows for efficiency and convenience, enabling patients to attain their intended results with a single powerful 1500 mg dose. For example, in August 2023, BDR Pharmaceuticals Internationals Pvt. Ltd., an India-based company specializing in API (active pharmaceutical ingredient) and formulation therapeutic segments such as acute bacterial skin, and skin structure infections, unveiled Dalbonova injection. This particular single-dose therapy is for the treatment of acute bacterial skin and skin structure infections (ABSSSI). The Dalbonova injection potentially minimizes the likelihood of contracting diseases in hospitals by providing a single-dose solution and cutting the need for hospitalization. Its purpose is to counter acute bacterial skin and skin structure infections (ABSSSI) resulting from specific gram-positive organisms in patients encompassing all age groups, including newborns.
Pre-order Your Report for Quick and Easy Delivery!
How Are Key Segments Defining the Competitive Landscape of the Acute Bacterial Skin And Skin Structure Infections Market?
The acute bacterial skin and skin structure infections market covered in this report is segmented –
1) By Type Of Infection: Hospital-Acquired Acute Bacterial Skin And Skin Structure Infections, Community-Acquired Acute Bacterial Skin And Skin Structure Infections
2) By Active Ingredients: Delafloxacin, Vancomycin, Ceftaroline Fosamil, Oritavancin, Tedizolid, Daptomycin, Tigecycline, Linezolid, Other Active Ingredients
3) By Route Of Administration: Oral, Parenteral, Topical
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By Application: Cellulitis, Abscess, Surgical Wounds, Traumatic Wound
Subsegments:
1) By Hospital-Acquired Acute Bacterial Skin And Skin Structure Infections (HABSSSIs): Surgical Site Infections, Catheter-Related Infections, Pressure Ulcers, Infections Related To Medical Devices
2) By Community-Acquired Acute Bacterial Skin And Skin Structure Infections (CABSSSIs): Cellulitis, Abscesses, Impetigo, Folliculitis, Wound Infections
What Regions Are Contributing Significantly to the Growth of the Acute Bacterial Skin And Skin Structure Infections Market?
Asia-Pacific was the largest region in the acute bacterial skin and skin structure infections market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the acute bacterial skin and skin structure infections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
How Is the Scope and Reach of the Acute Bacterial Skin And Skin Structure Infections Market Defined?
Acute bacterial skin and skin structure infections (ABSSSIs) are a type of skin infection caused by bacteria that affect the skin and underlying tissues, leading to symptoms such as redness, swelling, pain, and warmth in the affected area. Medical interventions, such as antibiotic treatment, are used to prevent complications and promote healing in mild to severe infections.
Browse Through More Similar Reports By The Business Research Company:
Taste Masking And Taste Assessment Services And Technologies Global Market Report 2024
Antibacterial Products Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antibacterial-products-global-market-report
Double-Sided Masking Tapes Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/double-sided-masking-tapes-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
